Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-04-03Clinical Trial Update: Etirinotecan Pegol (NKTR-102) in NSCLC [Phase 2]
A Phase 2 trial of Etirinotecan Pegol (NKTR-102) in metastatic and recurrent non-small cell lung cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-04-03Clinical Trial Update: Analysis of Gut Microbiota in Patients With Brain Metastasis of Non-small Cell Lung Cancer Treated by Pembrolizumab Combined With Chemotherapy [Phase 1, Phase 2]
Phase 1/2 trial update examining how gut microbiota relates to outcomes in brain metastasis from non-small cell lung cancer treated with pem…
-
CLINICAL_TRIALS trial_result · 2020-04-03Clinical Trial Update: Study of Anlotinib in Non-squamous NSCLC Patients Who Failed First-Line（ALTER-L020） [Phase 4]
Phase 4 study updates the use of anlotinib in patients with non-squamous non-small cell lung cancer after failure of first-line therapy.
-
CLINICAL_TRIALS trial_result · 2020-04-02Clinical Trial Update: Low-dose Gemcitabine Combined With Nivolumab for Second-line and Above Line Treatment of NSCLC [Phase 4]
Phase 4 trial investigating low-dose gemcitabine in combination with nivolumab for second-line and later treatment in metastatic non-small c…
-
CLINICAL_TRIALS trial_result · 2020-03-26Clinical Trial Update: Aprepitant for Chemotherapy Induced Nausea and Vomiting in Chinese Advanced Non-small Cell Lung Cancers [Phase 3]
Phase 3 trial updating aprepitant for chemotherapy-induced nausea and vomiting in Chinese patients with advanced non-small cell lung cancer …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-03-20Clinical Trial Update: Phase I Study of Lurbinectedin (PM01183) in Combination With Paclitaxel, With or Without Bevacizumab, in Selected Advanced Solid Tumors [Phase 1]
Phase I study of lurbinectedin in combination with paclitaxel, with or without bevacizumab, in selected advanced solid tumors (completed; re…
-
CLINICAL_TRIALS trial_result · 2020-03-19Clinical Trial Update: Evaluation of FKB238 and Avastin in Patients With Advanced/Recurrent Non-squamous Non-small Cell Lung Cancer [Phase 3]
A Phase 3 trial evaluating FKB238 in combination with Avastin for advanced/recurrent non-squamous non-small cell lung cancer has completed w…
-
CLINICAL_TRIALS trial_result · 2020-03-18Clinical Trial Update: Anlotinib In Combination With PD-1/L1 Inhibitor As Sequential Therapy of Thoracic Radiotherapy After Induction Chemotherapy For Extensive-Stage Small Cell Lung Cancer:A Single Arm Study [Phase 2]
Phase 2 single-arm trial evaluating anlotinib with a PD-1/PD-L1 inhibitor as sequential therapy following thoracic radiotherapy after induct…
-
CLINICAL_TRIALS trial_result · 2020-03-18Clinical Trial Update: Local Non-salvage Radiotherapy for Synchronous Oligometastatic Non-small-cell Lung Cancer. [Phase 2]
Phase 2 clinical trial update investigating local non-salvage radiotherapy for patients with synchronous oligometastatic stage IV non-small …
-
CLINICAL_TRIALS trial_result · 2020-03-18Clinical Trial Update: Pemetrexed Disodium in Treating Patients With Stage IV Non-small Cell Lung Cancer and ECOG Performance Status 3 [Phase 2]
Phase 2 clinical trial evaluating pemetrexed disodium in stage IV non-small cell lung cancer with poor performance status (ECOG 3).
-
CLINICAL_TRIALS trial_result · 2020-03-17Clinical Trial Update: The Optimal Intervention Time of Radiotherapy for Oligometastatic Stage IV Non-small Cell Lung Cancer（NSCLC） [Phase 3]
Phase 3 trial evaluating optimal timing of radiotherapy in oligometastatic stage IV non-small cell lung cancer is ongoing, with status curre…
-
CLINICAL_TRIALS trial_result · 2020-03-13Clinical Trial Update: A Study of TQB2450 Injection Combined With Stereotactic Body Radiation Therapy (SBRT) in Subjects With Advanced Oligometastatic Non-Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating TQB2450 injection with SBRT in advanced oligometastatic non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2020-03-10Clinical Trial Update: Camrelizumab Combined With Endostar for First-line Treatment in Subjects With Advanced Squamous NSCLC [Phase 2]
Phase 2 trial update evaluating camrelizumab combined with Endostar as first-line treatment for advanced squamous non-small cell lung cancer…
-
CLINICAL_TRIALS trial_result · 2020-03-04Clinical Trial Update: A Study of Ramucirumab (LY3009806) in Combination With Erlotinib in Previously Untreated Participants With EGFR Mutation-Positive Metastatic NSCLC (RELAY) [Phase 3]
This clinical trial update reports on RELAY, a Phase 3 study evaluating the combination of ramucirumab with erlotinib in previously untreate…
-
CLINICAL_TRIALS trial_result · 2020-03-04Clinical Trial Update: Stereotactic Radiosurgery Combination With Anlotinib for Limited Brain Metastases With Perilesional Edema in NSCLC [Phase 2]
Phase 2 trial update investigating stereotactic radiosurgery with anlotinib for limited brain metastases in NSCLC with perilesional edema.
-
CLINICAL_TRIALS trial_result · 2020-02-25Clinical Trial Update: PD-1 Combined With Dasatinib for as Third-line Treatment for ARID1A Mutation Advanced NSCLC [Phase 2]
Phase 2 trial investigating PD-1 combined with dasatinib as third-line therapy for ARID1A-mutant advanced non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2020-02-25Clinical Trial Update: Cisplatin and Etoposide Plus Radiation Followed By Nivolumab/Placebo For Locally Advanced NSCLC [Phase 3]
A phase 3 trial evaluating cisplatin and etoposide with radiation followed by nivolumab vs placebo in locally advanced non-small cell lung c…
-
CLINICAL_TRIALS trial_result · 2020-02-24Clinical Trial Update: Locally Advanced NSCLC Hyperfractionated RT [Phase 2]
Phase 2 trial update on locally advanced non-small cell lung cancer using hyperfractionated radiotherapy; study completed with results poste…
-
CLINICAL_TRIALS trial_result · 2020-02-24Clinical Trial Update: Phase I Trial Of IMRT Using A Contralateral Esophagus Sparing Technique (CEST) In Locally Advanced Lung Cancer [NA]
Phase I trial evaluating a contralateral esophagus sparing technique (CEST) for IMRT in locally advanced lung cancer has completed with resu…
-
CLINICAL_TRIALS trial_result · 2020-02-21Clinical Trial Update: A Phase II Study to Evaluate the Efficacy and Safety of Oral Ceritinib in Patients With ALK-positive NSCLC Metastatic to the Brain and/or to Leptomeninges [Phase 2]
Phase II study evaluating oral ceritinib in ALK-positive non-small cell lung cancer with brain/leptomeningeal involvement; trial completed w…
-
CLINICAL_TRIALS trial_result · 2020-02-21Clinical Trial Update: Thoracic Re-irradiation For Locoregionally Recurrent Non-small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial investigating thoracic re-irradiation for locoregionally recurrent non-small cell lung cancer after prior thoracic ra…
-
CLINICAL_TRIALS trial_result · 2020-02-18Clinical Trial Update: Neoadjuvant Pembrolizumab [Phase 2]
Phase 2 neoadjuvant trial of pembrolizumab in non-small cell lung cancer has completed. Results were posted on 2020-02-18.
-
CLINICAL_TRIALS trial_result · 2020-02-18Clinical Trial Update: Gefitinib Versus Vinorelbine/Platinum as Adjuvant Treatment in Stage II-IIIA(N1-N2) NSCLC With EGFR Mutation [Phase 3]
A Phase 3 trial comparing gefitinib to vinorelbine/platinum as adjuvant therapy in Stage II-IIIA(N1-N2) non-small cell lung cancer with EGFR…
-
CLINICAL_TRIALS trial_result · 2020-02-17Clinical Trial Update: Apatinib Combined With Vinorelbine for Non-driver Gene Mutation Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating apatinib in combination with vinorelbine for advanced non-small cell lung cancer with non-driver gene mutations has…
-
CLINICAL_TRIALS trial_result · 2020-02-13Clinical Trial Update: Docetaxel in Treating Older Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer [Phase 2]
A phase 2 trial update examining docetaxel in older patients with locally advanced or metastatic non-small cell lung cancer.